Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

287 Press Releases
DateTitleCompany
04 Dec 13 Teva to Host 2014 Business Outlook Conference Call and Webcast on December 10, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Nov 13 Teva and Mylan Settle Copaxone® Patent Litigation in France, the UK and the Netherlands Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Nov 13 Teva Comments on Recent Article Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
19 Nov 13 Teva in Focus: New Therapeutic Entities - from Process to Product Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
11 Nov 13 Teva will pay the State of Israel NIS 2.540 billion ($718M) Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Oct 13 Teva Announces Departure of President and CEO Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Oct 13 Teva Announces FDA Approval of Generic TOBI® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Oct 13 Teva to Report Third Quarter 2013 Financial Results on October 31, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Oct 13 Teva Accelerates Cost Reduction Program Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
01 Oct 13 Teva Announces Launch of Generic Zemplar® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Sep 13 Teva In-Focus: A New Webinar Series for the Investment Community Focusing on Teva’s R&D Activities Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 Sep 13 Teva Announces Exclusive Launch of Generic ADENOSCAN® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
23 Sep 13 Teva Announces Favorable Court Ruling in AZILECT® Patent Infringement Litigation Against Mylan Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Sep 13 CORRECTING and REPLACING Teva Announces Exclusive Launch of Generic NIASPAN® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
20 Sep 13 Teva Announces Exclusive Launch of Generic NIASPAN® in the United States Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 Aug 13 Teva Reports Top-Line Results from Final Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associated with Bipolar I Disorder Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
14 Aug 13 Leading Proxy Advisory Firms Recommend Vote in Favor of All Proposals for Teva Pharmaceutical's Annual Meeting Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
13 Aug 13 Teva to Present at the Canaccord Genuity 33rd Annual Growth Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
16 Jul 13 Teva to Report Second Quarter 2013 Financial Results on August 1, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 Jun 13 Teva Launches Generic Version of Viagra® (sildenafil) in Countries Across Europe Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Jun 13 Teva Strengthens Respiratory Franchise with Acquisition of MicroDose Therapeutx Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 13 Teva to Present at the Goldman Sachs 34th Annual Global Healthcare Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
12 Jun 13 Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding Generic Protonix® (Pantoprazole) Tablets Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
30 May 13 Teva Announces FDA Acceptance of sNDA for a Higher Concentration Dose of COPAXONE® Given Three Times a Week Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
24 May 13 Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
29 Apr 13 Teva Expands Management Team with Appointment of Paul J. Sekhri as Group Executive Vice President, Global Business Development and Chief Strategy Officer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
25 Apr 13 Teva Establishes Global Specialty Medicines Group Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
17 Apr 13 Teva Presented New Data from Phase III Clinical Trial of Milprosa™ (Progesterone) Vaginal Ring at the 61st Annual Meeting of the Pacific Coast Reproductive Society Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
10 Apr 13 Teva to Report First Quarter 2013 Financial Results on May 2, 2013 Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
08 Apr 13 Teva-Handok Names Yoo Suk Hong as Chief Executive Officer Teva Pharmaceutical Industries Ltd.,
Published by
Business Wire
Advertising